Broadcom named strategic vendor for Walmart virtualization solutions
Shawn McCormick (NYSE:MKC), a director at Inspire Medical (TASE:BLWV) Systems, Inc. (NYSE:INSP), has recently sold shares of the company’s common stock. According to a filing with the Securities and Exchange Commission, McCormick sold 360 shares at a price of $160 each on May 2, 2025, totaling $57,600. The transaction comes as the $4.8 billion market cap medical device company trades near its current Fair Value, according to InvestingPro analysis, with the stock down about 36% over the past year.
This transaction was made under a Rule 10b5-1 trading plan dated November 13, 2024. Following the sale, McCormick holds 24,046 shares directly. Additionally, McCormick acquired 1,266 restricted stock units on May 1, 2025, which will vest based on certain conditions, including continued employment or a change of control scenario. McCormick also holds 3,000 shares indirectly through a trust. The company maintains strong financial health with a current ratio of 7.1x and minimal debt, while delivering impressive revenue growth of 28.5% in the last twelve months. Discover 13 additional key insights about INSP with a comprehensive Pro Research Report, available exclusively on InvestingPro.
In other recent news, Inspire Medical Systems has reported a strong financial performance for the first quarter of 2025, surpassing earnings expectations. The company achieved an earnings per share (EPS) of $0.10, significantly outperforming the anticipated loss of -$0.2433. Revenue for the quarter reached $201.3 million, marking a 23% increase compared to the same period last year. This growth was largely driven by the successful launch of the Inspire V system, which contributed to a 24% increase in US revenue, despite a 6% decline in revenue from international markets. Looking forward, Inspire Medical Systems expects full-year 2025 revenue to be between $940 million and $955 million, reflecting a growth of 17-19%. The company also anticipates a diluted net income of $2.20 to $2.30 per share for the year. Inspire Medical Systems plans to expand its market presence internationally, focusing on Europe and Asia. The launch of the Inspire V system has been well-received, and the company aims to capitalize on this momentum to drive further growth throughout the year.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.